In a patient with chronic migraines and worsening headache whose brain CT reveals a partially empty sella, should this be considered an incidental finding or warrant further endocrine and neuro‑ophthalmologic evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Partially Empty Sella in Chronic Migraine: Clinical Significance and Management

This partially empty sella is NOT just an incidental finding—you need to screen for pituitary dysfunction with comprehensive hormone testing, as 29% of incidentally discovered empty sella cases have hypopituitarism that can significantly impact morbidity and quality of life. 1

Why This Matters

While your patient came in for worsening migraines, the partially empty sella finding carries real endocrine risk that requires evaluation. The 2025 Pituitary Society international consensus guidelines specifically address this scenario and provide clear direction 1.

Key Evidence on Hypopituitarism Risk

In 402 patients with primary empty sella, 29% of those diagnosed incidentally had one or more pituitary hormone deficiencies 1. The breakdown shows:

  • Hypogonadism: 8.5% in incidental cases
  • Hypothyroidism: 2.8% in incidental cases
  • Hypocortisolism: 13.5% in incidental cases
  • Growth hormone deficiency: 12.5% in incidental cases

Critical point: Patients with partial empty sella have lower rates of hypopituitarism than total empty sella, but progression from partial to total can occur and is associated with hormonal deterioration (P = 0.006) 1.

What You Must Do Now

1. Complete Pituitary Hormone Evaluation

Screen all anterior pituitary axes:

  • Morning cortisol (if not diagnostic, proceed to ACTH stimulation test to confirm or exclude adrenal insufficiency)
  • TSH and free T4 (central hypothyroidism)
  • LH, FSH, testosterone (men) or estradiol (women) (hypogonadotropic hypogonadism)
  • Prolactin (can be elevated in 2.9% of incidental cases)
  • IGF-1 (growth hormone deficiency—though often underdiagnosed without dynamic testing)

2. Obtain Dedicated Pituitary MRI

The CT brain you ordered was appropriate for migraine evaluation, but CT is insufficient for characterizing sellar pathology. The 2025 guidelines explicitly show that dedicated sellar imaging with MRI is required 1:

  • Coronal and sagittal T1-weighted sequences with gadolinium
  • Axial T2-weighted sequences

This will:

  • Confirm the partially empty sella diagnosis
  • Exclude other pathology (Rathke cleft cyst, arachnoid cyst, occult adenoma)
  • Establish baseline for future comparison

3. Clinical Re-evaluation

Look specifically for subtle signs of hypopituitarism that may have been attributed to other causes:

  • Fatigue, cold intolerance (hypothyroidism)
  • Decreased libido, menstrual irregularities (hypogonadism)
  • Orthostatic symptoms, unexplained hypoglycemia (adrenal insufficiency)
  • Weight changes, decreased muscle mass (growth hormone deficiency)

Male sex, clinical suspicion of pituitary disease, and history of traumatic brain injury predict higher hypopituitarism risk (P = 0.02, P <0.001, P = 0.003 respectively) 1.

Regarding the Migraine Connection

The partially empty sella is almost certainly unrelated to your patient's worsening migraines. The 2025 Pituitary Society guidelines specifically cite a 25-year-old woman with an incidental Rathke cleft cyst detected during migraine evaluation as an example where initial imaging and clinical assessment enabled diagnosis without additional intervention 1. Primary empty sella has been shown NOT to cause a specific headache type 2.

However, don't dismiss the worsening headache pattern—continue appropriate migraine management per standard guidelines while addressing the empty sella separately.

Follow-Up Strategy

If Hormone Testing is Normal:

  • Repeat pituitary function testing in 24-36 months given the low but real risk of progression 3
  • Repeat MRI if clinical symptoms develop suggesting new hormone deficiency or if headache pattern changes dramatically

If Hypopituitarism is Detected:

  • Initiate appropriate hormone replacement (hydrocortisone for adrenal insufficiency, levothyroxine for hypothyroidism, sex hormone replacement for hypogonadism)
  • More frequent monitoring (annually or sooner if symptoms change)
  • Consider endocrinology referral for complex cases or multiple axis deficiencies

Common Pitfalls to Avoid

  1. Don't assume "partial" means "benign"—29% still have hormone deficiencies 1
  2. Don't rely on symptoms alone—the negative predictive value of absent symptoms is only 71% 1
  3. Don't skip the ACTH stimulation test if morning cortisol is borderline—adrenal insufficiency can be life-threatening
  4. Don't forget to recheck even if initial testing is normal—progression can occur over time 1

The evidence is clear: this finding requires action, not dismissal as incidental 1, 4, 5, 6.

References

Research

Primary Empty Sella.

Headache, 2020

Research

Empty sella syndrome: an update.

Pituitary, 2024

Research

A Comprehensive Review of Empty Sella and Empty Sella Syndrome.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2024

Related Questions

In a primary care patient with a partially empty sella identified on a CT scan performed for migraines, what is the appropriate management?
What are the anesthesia considerations for a patient with empty sella syndrome?
What is the association between empty sella syndrome and migraine?
Does a 62-year-old woman with headache and an empty sella require further evaluation?
Why would a person have an empty sella turcica?
How does piperacillin‑tazobactam compare to cefepime plus sulbactam 500 mg regarding antimicrobial spectrum, β‑lactamase inhibition, and safety in an adult with normal renal function?
For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?
What is the appropriate dose of piperacillin‑tazobactam for a patient with a creatinine clearance of 31 mL/min?
What is the recommended nitrofurantoin dosage for an uncomplicated urinary tract infection in adults and children, and what are the contraindications?
How should cabergoline be prescribed and monitored in non-pregnant patients, especially women of child‑bearing potential?
In an adult with acute coronary syndrome who has received a 180 mg ticagrelor loading dose and a 300‑325 mg aspirin loading dose, when should the first maintenance dose of ticagrelor be given?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.